Market Executive Summary
Often rare diseases are chronic and life-threatening. Rare diseases can be single gene, multifactorial, chromosomal or non-genetic.
Market Analysis and Insights: Global Rare Disease Diagnostics Market
The global Rare Disease Diagnostics market is projected to grow from US$ 22460 million in 2024 to US$ 36260 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Rare Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rare Disease Diagnostics, also provides the revenue of main regions and countries. of the upcoming market potential for Rare Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rare Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Rare Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Rare Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Global Rare Disease Diagnostics Companies Covered
Retrophin, 3billion, 23andMe, QIAGEN, Illumina, PerkinElmer, Strand Life Sciences
Global Rare Disease Diagnostics Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rare Disease Diagnostics Market, Segment by Type
Hematology
Oncology
Global Rare Disease Diagnostics Market, Segment by Application
Hospital Laboratories
Diagnostic Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Rare Disease Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Disease Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rare Disease Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Hematology
1.2.3 Oncology
1.3 Market by Application
1.3.1 Global Rare Disease Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Genetic Testing Laboratories
1.3.5 Cancer Research Laboratories
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Disease Diagnostics Market Perspective (2019-2030)
2.2 Global Rare Disease Diagnostics Growth Trends by Region
2.2.1 Rare Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rare Disease Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Rare Disease Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Rare Disease Diagnostics Market Dynamics
2.3.1 Rare Disease Diagnostics Industry Trends
2.3.2 Rare Disease Diagnostics Market Drivers
2.3.3 Rare Disease Diagnostics Market Challenges
2.3.4 Rare Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rare Disease Diagnostics by Players
3.1.1 Global Rare Disease Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Rare Disease Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Rare Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rare Disease Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Rare Disease Diagnostics Market Concentration Ratio
3.4.1 Global Rare Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Diagnostics Revenue in 2023
3.5 Global Key Players of Rare Disease Diagnostics Head office and Area Served
3.6 Global Key Players of Rare Disease Diagnostics, Product and Application
3.7 Global Key Players of Rare Disease Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Disease Diagnostics Breakdown Data by Type
4.1 Global Rare Disease Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Rare Disease Diagnostics Forecasted Market Size by Type (2025-2030)
5 Rare Disease Diagnostics Breakdown Data by Application
5.1 Global Rare Disease Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Rare Disease Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rare Disease Diagnostics Market Size (2019-2030)
6.2 North America Rare Disease Diagnostics Market Size by Type
6.2.1 North America Rare Disease Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Rare Disease Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Rare Disease Diagnostics Market Share by Type (2019-2030)
6.3 North America Rare Disease Diagnostics Market Size by Application
6.3.1 North America Rare Disease Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Rare Disease Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Rare Disease Diagnostics Market Share by Application (2019-2030)
6.4 North America Rare Disease Diagnostics Market Size by Country
6.4.1 North America Rare Disease Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Rare Disease Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Rare Disease Diagnostics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Rare Disease Diagnostics Market Size (2019-2030)
7.2 Europe Rare Disease Diagnostics Market Size by Type
7.2.1 Europe Rare Disease Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Rare Disease Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Rare Disease Diagnostics Market Share by Type (2019-2030)
7.3 Europe Rare Disease Diagnostics Market Size by Application
7.3.1 Europe Rare Disease Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Rare Disease Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Rare Disease Diagnostics Market Share by Application (2019-2030)
7.4 Europe Rare Disease Diagnostics Market Size by Country
7.4.1 Europe Rare Disease Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Rare Disease Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Rare Disease Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rare Disease Diagnostics Market Size (2019-2030)
8.2 China Rare Disease Diagnostics Market Size by Type
8.2.1 China Rare Disease Diagnostics Market Size by Type (2019-2024)
8.2.2 China Rare Disease Diagnostics Market Size by Type (2025-2030)
8.2.3 China Rare Disease Diagnostics Market Share by Type (2019-2030)
8.3 China Rare Disease Diagnostics Market Size by Application
8.3.1 China Rare Disease Diagnostics Market Size by Application (2019-2024)
8.3.2 China Rare Disease Diagnostics Market Size by Application (2025-2030)
8.3.3 China Rare Disease Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rare Disease Diagnostics Market Size (2019-2030)
9.2 Asia Rare Disease Diagnostics Market Size by Type
9.2.1 Asia Rare Disease Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Rare Disease Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Rare Disease Diagnostics Market Share by Type (2019-2030)
9.3 Asia Rare Disease Diagnostics Market Size by Application
9.3.1 Asia Rare Disease Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Rare Disease Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Rare Disease Diagnostics Market Share by Application (2019-2030)
9.4 Asia Rare Disease Diagnostics Market Size by Region
9.4.1 Asia Rare Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Rare Disease Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Rare Disease Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Retrophin
11.1.1 Retrophin Company Details
11.1.2 Retrophin Business Overview
11.1.3 Retrophin Rare Disease Diagnostics Introduction
11.1.4 Retrophin Revenue in Rare Disease Diagnostics Business (2019-2024)
11.1.5 Retrophin Recent Developments
11.2 3billion
11.2.1 3billion Company Details
11.2.2 3billion Business Overview
11.2.3 3billion Rare Disease Diagnostics Introduction
11.2.4 3billion Revenue in Rare Disease Diagnostics Business (2019-2024)
11.2.5 3billion Recent Developments
11.3 23andMe
11.3.1 23andMe Company Details
11.3.2 23andMe Business Overview
11.3.3 23andMe Rare Disease Diagnostics Introduction
11.3.4 23andMe Revenue in Rare Disease Diagnostics Business (2019-2024)
11.3.5 23andMe Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Rare Disease Diagnostics Introduction
11.4.4 QIAGEN Revenue in Rare Disease Diagnostics Business (2019-2024)
11.4.5 QIAGEN Recent Developments
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Rare Disease Diagnostics Introduction
11.5.4 Illumina Revenue in Rare Disease Diagnostics Business (2019-2024)
11.5.5 Illumina Recent Developments
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Rare Disease Diagnostics Introduction
11.6.4 PerkinElmer Revenue in Rare Disease Diagnostics Business (2019-2024)
11.6.5 PerkinElmer Recent Developments
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Details
11.7.2 Strand Life Sciences Business Overview
11.7.3 Strand Life Sciences Rare Disease Diagnostics Introduction
11.7.4 Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2019-2024)
11.7.5 Strand Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures
List of Tables
Table 1. Global Rare Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Hematology
Table 3. Key Players of Oncology
Table 4. Global Rare Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Rare Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Rare Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Rare Disease Diagnostics Market Share by Region (2019-2024)
Table 8. Global Rare Disease Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Rare Disease Diagnostics Market Share by Region (2025-2030)
Table 10. Rare Disease Diagnostics Market Trends
Table 11. Rare Disease Diagnostics Market Drivers
Table 12. Rare Disease Diagnostics Market Challenges
Table 13. Rare Disease Diagnostics Market Restraints
Table 14. Global Rare Disease Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Rare Disease Diagnostics Revenue Share by Players (2019-2024)
Table 16. Global Top Rare Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2023)
Table 17. Global Rare Disease Diagnostics Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Rare Disease Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Rare Disease Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Rare Disease Diagnostics, Product and Application
Table 21. Global Key Players of Rare Disease Diagnostics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Rare Disease Diagnostics Revenue Market Share by Type (2019-2024)
Table 25. Global Rare Disease Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Rare Disease Diagnostics Revenue Market Share by Type (2025-2030)
Table 27. Global Rare Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Rare Disease Diagnostics Revenue Share by Application (2019-2024)
Table 29. Global Rare Disease Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Rare Disease Diagnostics Revenue Share by Application (2025-2030)
Table 31. North America Rare Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Rare Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Rare Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Rare Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Rare Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Rare Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Rare Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Rare Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Rare Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Rare Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Rare Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Rare Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Rare Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Rare Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Rare Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Rare Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Rare Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Rare Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Rare Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Rare Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Rare Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Rare Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Rare Disease Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Rare Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Rare Disease Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Rare Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 63. Retrophin Company Details
Table 64. Retrophin Business Overview
Table 65. Retrophin Rare Disease Diagnostics Product
Table 66. Retrophin Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Retrophin Recent Developments
Table 68. 3billion Company Details
Table 69. 3billion Business Overview
Table 70. 3billion Rare Disease Diagnostics Product
Table 71. 3billion Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 72. 3billion Recent Developments
Table 73. 23andMe Company Details
Table 74. 23andMe Business Overview
Table 75. 23andMe Rare Disease Diagnostics Product
Table 76. 23andMe Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 77. 23andMe Recent Developments
Table 78. QIAGEN Company Details
Table 79. QIAGEN Business Overview
Table 80. QIAGEN Rare Disease Diagnostics Product
Table 81. QIAGEN Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 82. QIAGEN Recent Developments
Table 83. Illumina Company Details
Table 84. Illumina Business Overview
Table 85. Illumina Rare Disease Diagnostics Product
Table 86. Illumina Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Illumina Recent Developments
Table 88. PerkinElmer Company Details
Table 89. PerkinElmer Business Overview
Table 90. PerkinElmer Rare Disease Diagnostics Product
Table 91. PerkinElmer Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 92. PerkinElmer Recent Developments
Table 93. Strand Life Sciences Company Details
Table 94. Strand Life Sciences Business Overview
Table 95. Strand Life Sciences Rare Disease Diagnostics Product
Table 96. Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Strand Life Sciences Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Disease Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Rare Disease Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Hematology Features
Figure 4. Oncology Features
Figure 5. Global Rare Disease Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Rare Disease Diagnostics Market Share by Application: 2023 VS 2030
Figure 7. Hospital Laboratories Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Genetic Testing Laboratories Case Studies
Figure 10. Cancer Research Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Rare Disease Diagnostics Report Years Considered
Figure 13. Global Rare Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Rare Disease Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Rare Disease Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Rare Disease Diagnostics Market Share by Players in 2023
Figure 17. Global Top Rare Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Rare Disease Diagnostics Revenue in 2023
Figure 19. North America Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Rare Disease Diagnostics Market Share by Type (2019-2030)
Figure 21. North America Rare Disease Diagnostics Market Share by Application (2019-2030)
Figure 22. North America Rare Disease Diagnostics Market Share by Country (2019-2030)
Figure 23. United States Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Rare Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Rare Disease Diagnostics Market Share by Type (2019-2030)
Figure 27. Europe Rare Disease Diagnostics Market Share by Application (2019-2030)
Figure 28. Europe Rare Disease Diagnostics Market Share by Country (2019-2030)
Figure 29. Germany Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Rare Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Rare Disease Diagnostics Market Share by Type (2019-2030)
Figure 37. China Rare Disease Diagnostics Market Share by Application (2019-2030)
Figure 38. Asia Rare Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Rare Disease Diagnostics Market Share by Type (2019-2030)
Figure 40. Asia Rare Disease Diagnostics Market Share by Application (2019-2030)
Figure 41. Asia Rare Disease Diagnostics Market Share by Region (2019-2030)
Figure 42. Japan Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Rare Disease Diagnostics Market Share by Country (2019-2030)
Figure 52. Brazil Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Rare Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Retrophin Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 59. 3billion Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 60. 23andMe Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 61. QIAGEN Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 62. Illumina Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 63. PerkinElmer Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 64. Strand Life Sciences Revenue Growth Rate in Rare Disease Diagnostics Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
